- ReneSola regained compliance required by the New York Stock Exchange for continued listing.
- Confirmation of compliance from the NYSE was received on October 1st, 2019.
- The Company had previously received notice that it did not meet the NYSE's price criteria back in September of this year.
Shanghai — ReneSola has regained compliance with the minimum average closing price criteria required by the New York Stock Exchange (the “NYSE”) for continued listing of the Company’s American Depositary Shares (“ADSs”).
On September 9, 2019, the Company received notice from the NYSE that it did not meet the NYSE’s price criteria for continued listing standard because the average closing price of the Company’s ADSs was less than US$1.00 per ADS over a consecutive 30-trading-day period.
Under NYSE rules, the Company has six months following receipt of the notification to regain compliance with the minimum share price requirement.
The Company can regain compliance at any time during the six-month cure period if the Company’s ADSs have a closing share price of at least US$1.00 on the last trading day of any calendar month during the period and also has an average closing share price of at least US$1.00 over the 30 trading-day period ending on the last trading day of that month or on the last day of the cure period.
On October 1, 2019, the Company received confirmation from the NYSE that it had regained compliance with continued listing standards after the average closing price for its ADSs for the consecutive 30-trading-day period ended September 30, 2019 exceeded US$1.00.